Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18460Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Fairchild, R. G. | en |
| dc.contributor.author | Kalef-Ezra, J. | en |
| dc.contributor.author | Packer, S. | en |
| dc.contributor.author | Wielopolski, L. | en |
| dc.contributor.author | Laster, B. H. | en |
| dc.contributor.author | Robertson, J. S. | en |
| dc.contributor.author | Mausner, L. | en |
| dc.contributor.author | Kanellitsas, C. | en |
| dc.date.accessioned | 2015-11-24T18:52:56Z | - |
| dc.date.available | 2015-11-24T18:52:56Z | - |
| dc.identifier.issn | 0031-9155 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18460 | - |
| dc.rights | Default Licence | - |
| dc.subject | *Brachytherapy | en |
| dc.subject | Brain Neoplasms/*radiotherapy | en |
| dc.subject | Eye Neoplasms/*radiotherapy | en |
| dc.subject | Humans | en |
| dc.subject | Models, Theoretical | en |
| dc.subject | Radioisotopes/*therapeutic use | en |
| dc.subject | Radiotherapy Dosage | en |
| dc.subject | Samarium/*therapeutic use | en |
| dc.title | Samarium-145: a new brachytherapy source | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/3615583 | - |
| heal.identifier.secondary | http://iopscience.iop.org/0031-9155/32/7/005/pdf/0031-9155_32_7_005.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1987 | - |
| heal.abstract | A new radiation source has been produced for brachytherapy, with radiation energies slightly above those of 125I, and a T1/2 of 340 d. This source, 145Sm, is produced by neutron irradiation of 144Sm (96.5% enriched). Decay is by electron capture with 140 K x-rays per 100 disintegrations in the energy region between 38-45 keV, plus 13 gamma-rays at 61 keV. These sources are encapsulated in Ti tubes, approximately 0.8 mm X 4.5 mm, and have been developed for temporary implantation in brain and ocular tumours. The 38-61 keV photons should make such sources easy to shield, while providing a dose distribution from source arrays somewhat more homogeneous than that from 125I. In addition, the 340 d half life of 145Sm permits its use for times significantly longer than that of 60 d 125I. While the 145Sm sources have been designed primarily for implantation in a brain tumour, they should be useful for almost any conventional brachytherapy application. | en |
| heal.journalName | Phys Med Biol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Fairchild-1987-Samarium-145_ a new.pdf | 726.73 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
